IART vs KEYS · rev $810.7M vs P/E 57, rev $5.16B
Integra LifeSciences Holdings (IART) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported IART revenue for 2026-06-30 was $810.7M. Net income was -$134.0K. IART currently screens at market cap $1.32B.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
IART currently screens at market cap $1.32B. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the IART and KEYS stock pages for the full models.
Not investment advice.